{
  "nctId": "NCT05094661",
  "briefTitle": "Predictors of Non-invasive Respiratory Support Failure in COVID-19 Pneumonia",
  "officialTitle": "Predictors of Non-invasive Respiratory Support Failure in COVID-19 Pneumonia",
  "protocolDocument": {
    "nctId": "NCT05094661",
    "filename": "Prot_SAP_002.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2021-01-21",
    "uploadDate": "2022-08-24T12:06",
    "size": 281456,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT05094661/document/Prot_SAP_002.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "SINGLE",
  "enrollmentInfo": {
    "enrollmentCount": 135,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2021-02-18",
    "completionDate": "2022-11-07",
    "primaryCompletionDate": "2022-11-07",
    "firstSubmitDate": "2021-04-22",
    "firstPostDate": "2021-10-26"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Age â‰¥18 years.\n* Severe hypoxemic respiratory failure (partial pressure of arterial oxygen/ fraction of inspired oxygen \\< 250 mmHg).\n* Confirmed SARS-Cov2 infection.\n* Radiological images compatible with pneumonia covid.\n\nExclusion Criteria:\n\n* Hypoxemic respiratory failure secondary to a cause other than SARS-Cov2 pneumonia.\n* Hypercapnic respiratory failure.\n* Patient with criteria of orotracheal intubation at admission.\n* Glasgow \\< 15\n* Haemodynamic instability that needs drugs treatment\n* Patients with swallowing problems that conditioned an aspiration pneumonia risk.",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Failure of High Flow Nasal Cannula",
        "description": "The number of patients with respiratory work or desaturation at the beginning of therapy with high-flow nasal cannulas will be measured. This will be defined with desaturation below 90%, respiratory rate greater than 30 o pO2 below 60 despite receiving a maximum support of 60 liters per minute and with 100% FIO2.",
        "timeFrame": "From the start of High Flow Nasal Cannula support to intubation and invasive ventilation or death at 30 days."
      },
      {
        "measure": "Failure of Non Invasive Ventilation",
        "description": "The number of patients with respiratory work or desaturation and who need orotracheal intubation or die will be measured. This will be defined with desaturation below 90%, respiratory rate above 30 o pO2 below 60 despite receiving a maximum pressure support and with 100% FIO2.",
        "timeFrame": "From the start of CPAP or BIPAP to intubation and invasive ventilation or death at 30 days"
      }
    ],
    "secondary": [
      {
        "measure": "90-day at home recovery",
        "description": "Compare the degree of pre-admission mMRC dyspnea with the degree of mMRC dyspnea 90 days after inclusion in the study.",
        "timeFrame": "From the inclusion to 90 days after inclusion in the study."
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 2,
      "secondaryCount": 1,
      "otherCount": 0,
      "totalCount": 3
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 54,
    "complexityCategory": "Complex"
  },
  "collectionDate": "2025-09-22T02:30:36.595Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}